C. Prehn

Dr. C. Prehn is a researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, specializing in cancer epidemiology with a focus on metabolomics approaches. They are actively involved in the European Prospective Investigation into Cancer and Nutrition (EPIC) study and other population-based cohort studies examining the relationship between metabolic profiles and disease risk.

Dr. Prehn's research primarily investigates how circulating metabolites—including lipids, amino acids, and other biomarkers—are associated with colorectal cancer risk and cardiovascular disease. Their work uses advanced metabolomics techniques to identify metabolic signatures that may serve as early indicators of disease development. They have made significant contributions to understanding how lifestyle factors influence metabolic profiles and subsequent disease risk.

Through analysis of large prospective cohort data, Dr. Prehn has published numerous studies examining the relationship between pre-diagnostic metabolite levels and subsequent cancer development. Their research spans methodological development in metabolomic data analysis to applied epidemiological studies investigating specific disease associations. The consistent focus across their publications is on identifying early metabolic markers of disease that could inform prevention strategies and early detection approaches.

Dr. Prehn maintains active collaborations across European research institutions, particularly through the EPIC study consortium, and has developed expertise in both the technical aspects of metabolomic profiling and the statistical methods needed to analyze complex metabolomic datasets in epidemiological contexts.